Delivery Order SPE2DB22D1017-SPE2DB25FYQCF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,827.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. This non-set-aside award, issued on August 21, 2025, carries a ceiling value of $9,966.92 and is scheduled for completion by August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $15,801.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,431.30 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $14,787.00. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $29,840.86 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,044.18 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) under a firm fixed-price contract. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and represents a competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work...
- The Defense Logistics Agency awarded a delivery order valued at $95,172.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 26, 2025, with completion targeted for August 27, 2025. This competitive award, issued under firm fixed pricing terms, supports federal medical procurement needs through AmerisourceBergen's established supply chain. The contract specifies performance from the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,703.72 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYQCFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,282.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price procurement with no set-aside designation, indicating the award was competitively available. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare programs globally. The parent IDC structure allows the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems to procure critical pharmaceutical products through flexible delivery orders, with this particular award supporting the federal government's ongoing pharmaceutical supply requirements for military and defense operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.3k | 9/5/25 |